Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Neoplasms 1Fatigue 1Anorexia 1

Interventions

Megestrol Acetate 11Mirtazapine 5Olanzapine 4anamorelin 2Infliximab 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1EOM613 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anorexia × EOM613 × Clear all
NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown
20 enrolled

Anorexia, Fatigue, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡